Diebold Nixdorf (DBD) Misses Q4 EPS by 3c, Offers FY Guidance
Get Alerts DBD Hot Sheet
Price: $82.88 -1.11%
EPS Growth %: +30.9%
Financial Fact:
Net income attributable to Diebold, Incorporated: -0.32
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +30.9%
Financial Fact:
Net income attributable to Diebold, Incorporated: -0.32
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q4 EPS of $0.47, $0.03 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $1.15 billion versus the consensus estimate of $1.16 billion.
GUIDANCE:
Diebold Nixdorf sees FY2020 revenue of $4.2-4.3 billion, versus the consensus of $4.27 billion.
- Full-year 2020 Outlook1 2020 Outlook Total Revenue $4.2 billion - $4.3 billion Adjusted EBITDA2 $430 million - $470 million Net cash provided by operating activities $170 million - $200 million Capital expenditures ~ ($70 million) Free cash flow $100 million - $130 million 1 - The company's 2020 outlook includes the impact of deconsolidating two joint ventures in China, which was finalized in the first quarter 2020, and the divestiture of Diebold Nixdorf Portavis GmbH, which is expected to be finalized in the first quarter 2020.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Ennis (EBF) Reports In-Line Q1 EPS
- MP Materials seen largely insulated after China export-control move
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share